» Articles » PMID: 16973114

Recent Advances in the Genetics of Rheumatoid Arthritis

Overview
Publisher Current Science
Specialty Rheumatology
Date 2006 Sep 16
PMID 16973114
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Recent progress in defining the role of genetic factors in rheumatoid arthritis (RA) has been remarkable. Anticyclic citrullinated peptide (anti-CCP) antibody-positive disease appears to be immunogenetically distinct from anti-CCP-negative disease, with the former subgroup primarily responsible for association and linkage with the HLA-DRB1 shared epitope (SE). There is preliminary evidence that non-HLA genes contribute differentially to anti-CCP-positive and negative disease. The phenotypic differences evident in anti-CCP-positive and negative disease suggest a need to reclassify RA based on the presence or absence of this autoantibody. Some recent work also suggests marked interactions between cigarette smoking, anti-CCP antibodies, and the SE, though these relationships may vary across populations. Lastly, a recent single nucleotide polymorphism-based genome-wide linkage analysis of multicase RA families revealed novel genomic regions that likely contain genes that predispose to RA or more specific phenotypes.

Citing Articles

Recent Advances in Drug Delivery Approaches for Rheumatoid Arthritis.

Verma A, Patel P, Almalki W, Almalki W, Sahebkar A, Kurmi B Curr Med Chem. 2023; 32(2):396-415.

PMID: 37581524 DOI: 10.2174/0929867331666230815112818.


Crosslinks Between Human Leukocyte Antigen DRB1*01 and Human Leukocyte Antigen DRB1*13 Allelic Variants and Occurrence of Rheumatoid Arthritis in Patients From Federation of Bosnia and Herzegovina.

Fejzic E, Sahovic A, Sisic S, Alijagic A, Suljevic D Arch Rheumatol. 2018; 32(4):290-297.

PMID: 29901021 PMC: 5868391. DOI: 10.5606/ArchRheumatol.2017.6258.


Identifying a major locus that regulates spontaneous arthritis in IL-1ra-deficient mice and analysis of potential candidates.

Jiao Y, Jiao F, Yan J, Xiong Q, Shriner D, Hasty K Genet Res (Camb). 2011; 93(2):95-103.

PMID: 21414240 PMC: 3245888. DOI: 10.1017/S0016672310000704.


Epigenetic modifications in rheumatoid arthritis.

Strietholt S, Maurer B, Peters M, Pap T, Gay S Arthritis Res Ther. 2008; 10(5):219.

PMID: 18947370 PMC: 2592785. DOI: 10.1186/ar2500.


Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004.

Sundquist K, Martineus J, Li X, Hemminki K, Sundquist J Rheumatology (Oxford). 2008; 47(8):1199-202.

PMID: 18524808 PMC: 2734284. DOI: 10.1093/rheumatology/ken184.


References
1.
Begovich A, Carlton V, Honigberg L, Schrodi S, Chokkalingam A, Alexander H . A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75(2):330-7. PMC: 1216068. DOI: 10.1086/422827. View

2.
Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L . A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004; 50(10):3085-92. DOI: 10.1002/art.20553. View

3.
van Gaalen F, Linn-Rasker S, van Venrooij W, de Jong B, Breedveld F, Verweij C . Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004; 50(3):709-15. DOI: 10.1002/art.20044. View

4.
Hill J, Southwood S, Sette A, Jevnikar A, Bell D, Cairns E . Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003; 171(2):538-41. DOI: 10.4049/jimmunol.171.2.538. View

5.
van der Helm-van Mil A, Verpoort K, Breedveld F, Huizinga T, Toes R, de Vries R . The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 2006; 54(4):1117-21. DOI: 10.1002/art.21739. View